Skip to main content
logo
Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5069
+0.0132 (2.67%)
Sep 10, 2026, 11:29 AM EDT - Market open

Impact BioMedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
555317---
Market Cap Growth
641.36%216.73%----
Enterprise Value
557925---
Last Close Price
0.490.511.45---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1520.901651.05----
PB Ratio
4.943.402.31---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1520.612459.96----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--1.230.430.310.31
Net Debt / Equity Ratio
0.0000.950.430.310.31
Net Debt / EBITDA Ratio
0.000.00-2.03-3.00-4.36-6.02
Net Debt / FCF Ratio
0.020.00-2.41-4.21-3.97-6.16
Asset Turnover
0.000.00--0.00-
Quick Ratio
0.010.010.200.0100.00
Current Ratio
0.160.350.250.030.010.02
Return on Equity (ROE)
23.46%-104.16%-139.55%-14.46%-19.99%-4.52%
Return on Assets (ROA)
-17.79%-14.16%-6.54%-5.53%-4.13%-3.81%
Return on Capital Employed (ROCE)
-34.70%-26.30%-32.30%-12.80%-9.50%-7.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
1.49%-22.41%-148.12%---
FCF Yield
-0.95%-3.58%-17.11%---
Buyback Yield / Dilution
-571.61%-193.30%82.14%14.54%0.00%-
SEC Filings: 10-K · 10-Q